相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrophage-mediated cholesterol handling in atherosclerosis
Dimitry A. Chistiakov et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
The Future of Cardiovascular Epidemiology
Ramachandran S. Vasan et al.
CIRCULATION (2016)
Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Ira Tabas et al.
CIRCULATION RESEARCH (2016)
C-reactive protein/oxidized low density lipoprotein/β2-glycoprotein I complexes induce lipid accumulation and inflammatory reaction in macrophages via p38/mitogen-activated protein kinase and nuclear factor-κB signaling pathways
Jie Wang et al.
MOLECULAR MEDICINE REPORTS (2016)
Interleukin 34: a new modulator of human and experimental inflammatory bowel disease
Stephanie Zwicker et al.
CLINICAL SCIENCE (2015)
IL-34 Is Associated with Obesity, Chronic Inflammation, and Insulin Resistance
Eun-Ju Chang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Foam cells in atherosclerosis
Xiao-Hua Yu et al.
CLINICA CHIMICA ACTA (2013)
Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation
Kyoung-jin Min et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes
Francesco Ciccia et al.
RHEUMATOLOGY (2013)
Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients
M. Chemel et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis
Xavier Le Guezennec et al.
CELL METABOLISM (2012)
Increased Serum Interleukin-34 in Patients with Coronary Artery Disease
Zhenglong Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
NF-κB, Inflammation, and Metabolic Disease
Rebecca G. Baker et al.
CELL METABOLISM (2011)
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
The Nuclear Factor NF-κB Pathway in Inflammation
Toby Lawrence
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis
Alan R. Tall et al.
CELL METABOLISM (2008)
Discovery of a cytokine and its receptor by functional screening of the extracellular proteome
Haishan Lin et al.
SCIENCE (2008)
Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease
Carlos Fernández-Hernando et al.
CELL METABOLISM (2007)
Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation
Valerie Ferreira et al.
ATHEROSCLEROSIS (2007)
ABCAI, ABCGI and SR-BI: hormonal regulation in primary rat hepatocytes and human cell lines
Marita Sporstol et al.
BMC MOLECULAR BIOLOGY (2007)
MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits
B Kaminska
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
VV Kunjathoor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL
M Zhao et al.
APMIS (2002)
Oxidized LDL-induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients
M Janabi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
